Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor

Clinical Cancer Research

Volumn 17, Issue 1, 2011, Pages 31-38

  Bourdeaut, Franck ^a,b   Lequin, Delphine ^c   Brugières, Laurence ^d   Reynaud, Stéphanie ^c   Dufour, Christelle ^d   Doz, François ^c,e   André, Nicolas ^f   Stephan, Jean Louis ^g,h   Pérel, Yves ^i,j   Oberlin, Odile ^d   Orbach, Daniel ^c   Bergeron, Christophe ^k   Rialland, Xavier ^l   Fréneaux, Paul ^c   Ranchere, Dominique ^k   Figarella Branger, Dominique ^f   Audry, Georges ^m,n   Puget, Stéphanie ^e,o   Evans, D Gareth ^p   Ferreres Pinas, Joan Carles ^q   Capra, Valeria ^r   Mosseri, Véronique ^c   Coupier, Isabelle ^s   Gauthier Villars, Marion ^c   Pierron, Gaelle ^c   Delattre, Olivier ^b,c   more..

^a NANTES UNIVERSITY HOSPITAL   (France)

^b INSTITUT CURIE   (France)

^c INSTITUT CURIE   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f TIMONE HOSPITAL   (France)

^g HÔPITAL NORD   (France)

^h UNIVERSITÉ JEAN MONNET   (France)

ⁱ HÔPITAL PELLEGRIN   (France)

^j UNIVERSITÉ DE BORDEAUX   (France)

^k CENTRE LÉON BÉRARD   (France)

^l ANGERS UNIVERSITY HOSPITAL   (France)

^m University of the Mediterranean Aix Marseille II   (France)

ⁿ SORBONNE UNIVERSITÉ   (France)

^o HÔPITAL NECKER ENFANTS MALADES   (France)

^p ST MARY S HOSPITAL   (United Kingdom)

^q HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^r G GASLINI INSTITUTE   (Italy)

^s MONTPELLIER UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CHROMOSOME MOSAICISM; CLINICAL ARTICLE; GENE DELETION; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC COUNSELING; GERMLINE MUTATION; HSNF5/INI1 GENE; HUMAN; HUMAN TISSUE; OVERALL SURVIVAL; PARENT; POINT MUTATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RHABDOID TUMOR; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; WILD TYPE;

EID: 78751627817     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-1795     Document Type: Article

References (33)

1. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study. Cancer 1978;41:1937-48.
2. Tsuneyoshi M, Daimaru Y, Hashimoto H, Enjoji M. The existence of rhabdoid cells in specified soft tissue sarcomas. Histopathological, ultrastructural and immunohistochemical evidence. Virchows Arch A Pathol Anat Histopathol 1987;411:509-14.
3. Rorke LB, Packer R, Biegel J. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. J Neurooncol 1995;24:21-8.
4. Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999;59:74-9.
5. Sevenet N, Lellouch-Tubiana A, Schofield D, Hoang-Xuan K, Gessler M, Birnbaum D, et al. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet 1999;8:2359-68.
6. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 1998;394:203-6.
7. Ammerlaan AC, Ararou A, Houben MP, Baas F, Tijssen CC, Teepen JL, et al. Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome. Br J Cancer 2008;98:474-9.
8. Fernandez C, Bouvier C, Sevenet N, Liprandi A, Coze C, Lena G, et al. Congenital disseminated malignant rhabdoid tumor and cerebellar tumor mimicking medulloblastoma in monozygotic twins: pathologic and molecular diagnosis. Am J Surg Pathol 2002;26:266-70.
9. Janson K, Nedzi LA, David O, Schorin M, Walsh JW, Bhattacharjee M, et al. Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation. Pediatr Blood Cancer 2006;47:279-84.
10. Lee HY, Yoon CS, Sevenet N, Rajalingam V, Delattre O, Walford NQ. Rhabdoid tumor of the kidney is a component of the rhabdoid predisposition syndrome. Pediatr Dev Pathol 2002;5:395-9.
11. Sevenet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet 1999;65:1342-8.
12. Fujita M, Sato M, Nakamura M, Kudo K, Nagasaka T, Mizuno M, et al. Multicentric atypical teratoid/rhabdoid tumors occurring in the eye and fourth ventricle of an infant: case report. J Neurosurg 2005;102:299-302.
13. Kordes U, Gesk S, Fruhwald MC, Graf N, Leuschner I, Hasselblatt M, et al. Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor. Gene Chromosome Canc 2010; 49:176-81.
14. Taylor MD, Gokgoz N, Andrulis IL, Mainprize TG, Drake JM, Rutka JT. Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. Am J Hum Genet 2000;66:1403-6.
15. Bourdeaut F, Freneaux P, Thuille B, Lellouch-Tubiana A, Nicolas A, Couturier J, et al. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. J Pathol 2007;211:323-30.
16. Tuefferd M, De Bondt A, Van Den Wyngaert I, Talloen W, Verbeke T, Carvalho B, et al. Genome-wide copy number alterations detection in fresh frozen and matched FFPE samples using SNP 6.0 arrays. Genes Chromosomes Cancer 2008;47:957-64.
17. Jackson EM, Shaikh TH, Gururangan S, Jones MC, Malkin D, Nikkel SM, et al. High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor. Hum Genet 2007;122:117-27.
18. Tomlinson GE, Breslow NE, Dome J, Guthrie KA, Norkool P, Li S , et al. Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol 2005;23:7641-5.
19. Tekautz TM, Fuller CE, Blaney S, Fouladi M, Broniscer A, Merchant TE, et al. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 2005;23:1491-9.
20. Schneppenheim R, Fruhwald MC, Gesk S, Hasselblatt M, Jeibmann A, Kordes U, et al. Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am J Hum Genet;86:279-84.
21. Bacci C, Sestini R, Provenzano A, Paganini I, Mancini I, Porfirio B, et al. Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation. Neurogenetics 2010;11:73-80.
22. Boyd C, Smith MJ, Kluwe L, Balogh A, Maccollin M, Plotkin SR. Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet 2008;74:358-66.
23. Hadfield KD, Newman WG, Bowers NL, Wallace A, Bolger C, Colley A, et al. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. J Med Genet 2008;45:332-9.
24. Hulsebos TJ, Kenter SB, Jakobs ME, Baas F, Chong B, Delatycki MB. SMARCB1/INI1 maternal germ line mosaicism in schwannomatosis. Clin Genet 2010;77:86-91.
25. Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P. Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet 2007;80:805-10.
26. Swensen JJ, Keyser J, Coffin CM, Biegel JA, Viskochil DH, Williams MS. Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1. J Med Genet 2009;46:68-72.
27. Sestini R, Bacci C, Provenzano A, Genuardi M, Papi L. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. Hum Mutat 2008;29:227-31.
28. Ammerlaan AC, Houben MP, Tijssen CC, Wesseling P, Hulsebos TJ. Secondary meningioma in a long-term survivor of atypical teratoid/rhabdoid tumour with a germline INI1 mutation. Childs Nerv Syst 2008;24:855-7.
29. Kusafuka T, Miao J, Yoneda A, Kuroda S, Fukuzawa M. Novel germline deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor. Genes Chromosomes Cancer 2004;40:133-9.
30. Lafay-Cousin L, Payne E, Strother D, Chernos J, Chan M, Bernier FP. Goldenhar phenotype in a child with distal 22q11.2 deletion and intracranial atypical teratoid rhabdoid tumor. Am J Med Genet A 2009;149A:2855-9.
31. Wieser R, Fritz B, Ullmann R, Muller I, Galhuber M, Storlazzi CT, et al. Novel rearrangement of chromosome band 22q11.2 causing 22q11 microdeletion syndrome-like phenotype and rhabdoid tumor of the kidney. Hum Mutat 2005;26:78-83.
32. Lundin J, Soderhall C, Lunden L, Hammarsjo A, White I, Schoumans J, et al. 22q11.2 microduplication in two patients with bladder exstrophy and hearing impairment. Eur J Med Genet 2010;53:61-5.
33. Draaken M, Reutter H, Schramm C, Bartels E, Boemers TM, Ebert AK, et al. Microduplications at 22q11.21 are associated with non-syndromic classic bladder exstrophy. Eur J Med Genet. 2010;53:55-60.